Tirzepatide has a half-life of approximately 5 days, which means it takes about 25 to 30 days for the drug to fully clear your body after your last injection. That timeline applies whether you’re taking it as Mounjaro for type 2 diabetes or as Zepbound for weight loss, and it holds true across all dose levels.
What the 5-Day Half-Life Means
A half-life is the time it takes for the amount of drug in your blood to drop by half. With tirzepatide’s 5-day half-life, roughly half the medication is gone after 5 days, three-quarters after 10 days, and so on. Drugs are generally considered cleared from the body after about five to six half-lives, which is how you get to that 25-to-30-day window.
This is notably longer than many medications people are used to taking. It’s also why tirzepatide is dosed once per week rather than daily. The drug is a large peptide molecule that your body breaks down gradually through natural protein-digesting processes, not through your liver or kidneys in the way most pills are metabolized.
Kidney and Liver Problems Don’t Change the Timeline
FDA clinical pharmacology data shows that kidney disease, even severe cases including end-stage kidney disease, does not meaningfully change how long tirzepatide stays in the body. The same is true for liver impairment across all severity levels. The drug’s blood levels, peak concentration, and half-life remained essentially the same in people with organ impairment compared to those with normal function. This is likely because tirzepatide is broken down by general protein degradation throughout the body rather than being processed through a single organ.
Steady State Takes About 4 Weeks
If you’re starting tirzepatide rather than stopping it, the flip side of that long half-life is that the drug takes about four weeks of consistent weekly dosing to reach steady levels in your blood. Before that point, each injection is still building on the last one. This is part of why the dosing schedule starts low and increases gradually, and why meaningful changes in weight or blood sugar typically begin around that four-week mark.
How Long Side Effects Last After Stopping
Gastrointestinal side effects like nausea, bloating, and reduced appetite generally taper off within about a month of your last dose, which tracks closely with the drug’s clearance timeline. Some people experience a brief return of GI symptoms as their body adjusts to the medication’s absence, similar to the adjustment period when they first started. Once tirzepatide is fully out of your system, those drug-related side effects should resolve.
What does come back more permanently is appetite. Tirzepatide works partly by mimicking gut hormones that signal fullness to your brain. As the drug clears, hunger and appetite gradually return to their pre-treatment baseline, and weight regain is common without ongoing lifestyle changes or continued treatment.
Stopping Before Surgery
One of the most practical reasons people ask about clearance time is surgery. The American Society of Anesthesiologists recommends holding tirzepatide for at least one week before any elective procedure requiring anesthesia. This applies regardless of your dose or whether you’re taking it for diabetes or weight loss. The concern is that tirzepatide slows stomach emptying, which can leave food in your stomach longer than expected and raise the risk of aspiration (inhaling stomach contents) during sedation. Your surgical team may give you more specific instructions, including dietary guidance for the days before your procedure.
Switching to Another GLP-1 Medication
If you’re transitioning from tirzepatide to a different injectable like semaglutide (Ozempic, Wegovy), the overlap between the two drugs matters. Both have long half-lives and work on similar pathways, so taking them too close together can amplify side effects, especially nausea and vomiting. There are two common approaches: a one-to-two-week washout period, where you wait before starting the new medication, or a same-day switch, where you start the new drug on the day your next tirzepatide dose would have been scheduled. The washout approach is generally preferred for people who were already experiencing significant side effects. There is no single official guideline on the best method, so the decision is typically individualized.